DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Aarti Pharmalabs Limited — Analyst/Investor Meet Para A-XBRL

NSE 1 hr ago·22 Oct 2026, 10:41 am

Aarti Pharmalabs

Aarti Pharmalabs Limited has informed stock exchanges about an upcoming meeting with analysts and institutional investors. This event is scheduled for a specific date, as indicated in the company's filing.

For investors, this meeting is significant because it provides a platform for management to discuss the company's future strategy, financial performance, and operational outlook. It offers valuable insights into the company's direction and can help investors gauge management's confidence in upcoming projects.

Investors should watch for any updates regarding the company's growth plans, product pipeline, or guidance for future quarters. This information will be crucial for assessing the company's potential and making informed investment decisions.